Pfizer, Medivation's Dimebon Fails to Help Alzheimer's Patients
BusinessWeek
March 3 (Bloomberg) — Pfizer Inc. and Medivation Inc. said Dimebon, their experimental drug for Alzheimer's disease, failed to benefit patients in an advanced study. The trial, dubbed Connection, included 525 patients with …
Pfizer, Medivation disappointed with dimebon trialMarketWatch
Medivation, Pfizer drug fails Alzheimer's studyReuters
Pfizer Alzheimer's disease drug fails in studyThe Associated Press
TheStreet.com -FierceBiotech -Bizjournals.com
all 32 news articles »

No related posts.